Crunching the numbers for RMD... Refresh in a moment for the full analysis.
RESMED INC (RMD)
Healthcare
Deep Overvalued
mixed
$228.87
Updated: 2026-04-12
52
TradeApes Score
hold
Financial Strength
80
Strong
Operating Trend
33
Weak
Valuation
30
Weak
Capital Allocation
55
Mixed
Risk
80
Strong
Fair Value
$126.14
DCF Upside
-44.9%
Sector Rank
#14
of 29
Key Findings
+
Net cash position — more cash on hand than total debt
−
Sharp revenue decline — sales down more than 15% year over year
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.